PDF
INITIATION OF NEW SHARE BUYBACK PROGRAM
5.11.2026 07:20:01 CET | Ambu A/S | Changes in company's own shares
Ambu A/S is initiating a new share buyback program, under which Ambu will repurchase shares for a total amount of up to DKK 400m. The program will be conducted in the period from 9 November 2026 until no later than 30 April 2027.
The share buyback program is being launched within the authority granted by the shareholders at the Annual General Meeting held on 14 December 2022, for the repurchase of up to 10% of the Company’s share capital, provided that the purchase price does not deviate by more than 10% from the most recently quoted market price for the Company’s B-shares at the time of the acquisition. Prior to the launch of the share buyback program, Ambu holds 8,641,687 treasury shares, equal to 3.2% of the Company’s share capital.
The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations, with the purpose of reducing the share capital as set out in Article 5(2)(a) in MAR.
Ambu has retained Danske Bank to act as lead manager of the share buyback program and purchase shares on behalf of Ambu. Danske Bank has also agreed under the contract to make its trading decisions in relation to the shares in the Company independently of, and without influence by, the Company.
Ambu reserves the right to suspend or terminate the share buyback program at any time. Should the share buyback program be suspended or terminated, Ambu will announce this in a company announcement, and the manager will stop buying back shares in the market.
Terms of the share buyback program
Under the share buyback program, Ambu may repurchase shares up to a maximum amount of DKK 400m, and no more than 10,000,000 shares, corresponding to approximately 3.7% of the share capital of the Company.
The shares will be purchased on Nasdaq Copenhagen (XCSE) and potentially other Multilateral platforms.
The shares bought back on each trading day may not exceed 15% of the average daily trading volume over the 20 trading days preceding the date of purchase.
Shares acquired under the share buyback program may not be bought at a price exceeding the higher of (i) the share price of the last independent transaction, and (ii) the highest independent bid on the shares on the trading venue where the transaction is executed. Further, shares may not be bought at a price deviating by more than 10% from the official price quoted on Nasdaq Copenhagen at the time of acquisition for the Company’s B-shares.
In accordance with the Safe Harbor Regulations, Ambu will as a minimum for every seventh trading day issue an announcement in respect of transactions made under the share buyback program.
Company announcement no. 3 2026/27.
Contacts
- Lisa Bedell Clive, Head of Investor Relations, +44 7385 420133, licl@ambu.com
- Tine Bjørn Schmidt, Director of Corporate Communications, +45 2264 0697, tisc@ambu.com
About Ambu A/S
Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,500+ Ambu team members are committed to delivering above and beyond.